336
Views
10
CrossRef citations to date
0
Altmetric
Drug Evaluation

Nebivolol and valsartan as a fixed-dose combination for the treatment of hypertension

, MD PhD & , MD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ismail Kocyigit, Eray Eroglu & Tevfik Ecder. (2017) Nebivolol can be used for combination therapy in patients with autosomal dominant polycystic kidney disease. Expert Opinion on Pharmacotherapy 18:4, pages 455-455.
Read now

Articles from other publishers (9)

Heba Abd El-Aziz & Abdallah M. Zeid. (2024) Derivatization-free conventional and synchronous spectrofluorimetric estimation of atenolol and amlodipine. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 305, pages 123532.
Crossref
Ragaa Magdy, Nermine V Fares, Maha Farouk & Ahmed Hemdan. (2023) A Novel, Sustainable, and Eco-Friendly Spectrophotometric and Chemometric Approach for Determination of Severely Overlapped Spectrum via Unified Regression Equation: Greenness and Whiteness Assessment. Journal of AOAC International.
Crossref
Ahmed Hemdan, Ragaa Magdy, Maha Farouk & Nermine V. Fares. (2022) Central composite design as an analytical optimization tool for the development of eco-friendly HPLC-PDA methods for two antihypertensive mixtures containing the angiotensin receptor blocker Valsartan: Greenness assessment by four evaluation tools. Microchemical Journal 183, pages 108105.
Crossref
Ragaa Magdy, Ahmed Hemdan, Nermine Victor Fares & Maha Farouk. (2022) Application of two different spectrophotometric approaches for the determination of a new antihypertensive combination: Graphical and statistical representation of the data. European Journal of Chemistry 13:3, pages 267-272.
Crossref
Sarah J Wang & Gary E Sander. (2020) Nebivolol/valsartan combination for the treatment of hypertension: a review. Future Cardiology.
Crossref
Dawn Battise, Cassie L. Boland & Donald S. Nuzum. (2018) Nebivolol/Valsartan: A Novel Antihypertensive Fixed-Dose Combination Tablet. Annals of Pharmacotherapy 53:4, pages 402-412.
Crossref
Arrigo F. G. Cicero, Masanari Kuwabara & Claudio Borghi. (2018) A Critical Review of Nebivolol and its Fixed-Dose Combinations in the Treatment of Hypertension. Drugs 78:17, pages 1783-1790.
Crossref
Jack Ishak, Michael Rael, Henry Punzi, Alan Gradman, Lynn M. Anderson, Mehul Patel, Sanjida Ali, William Ferguson & Joel Neutel. (2018) Additivity of nebivolol/valsartan single-pill combinations versus other single-pill combinations for hypertension. The Journal of Clinical Hypertension 20:1, pages 143-149.
Crossref
Alessandro Cannavo & Walter J. Koch. (2018) GRK2 as negative modulator of NO bioavailability: Implications for cardiovascular disease. Cellular Signalling 41, pages 33-40.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.